Responses
Infectious diseases
Protocol
Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.